Literature DB >> 33683810

Asymmetric Cobalt-Catalyzed Regioselective Hydrosilylation/Cyclization of 1,6-Enynes.

Yang'en You1, Shaozhong Ge1.   

Abstract

We report an enantioselective cobalt-catalyzed hydrosilylation/cyclization reaction of 1,6-enynes with secondary and tertiary hydrosilanes employing a catalyst generated in situ from the combination of Co(acac)2 and (R,Sp )-Josiphos. A wide range of oxygen-, nitrogen-, and carbon-tethered 1,6-enynes reacted with Ph2 SiH2 , (EtO)3 SiH, or (RO)2 MeSiH to afford the corresponding chiral organosilane products in high yields and up to >99 % ee. This cobalt-catalyzed hydrosilylation/cyclization also occurred with prochiral secondary hydrosilane PhMeSiH2 to yield chiral alkylsilanes containing both carbon- and silicon-stereogenic centers with excellent enantioselectivity, albeit with modest diastereoselectivity. The chiral organosilane products from this cobalt-catalyzed asymmetric hydrosilylation/cyclization could be converted to a variety of chiral five-membered heterocyclic compounds by stereospecific conversion of their C-Si and Si-H bonds without loss of enantiopurity.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  1,6-enyens; chiral alkylsilanes; cobalt; enantioselectivity; hydrosilylation/cyclization

Year:  2021        PMID: 33683810     DOI: 10.1002/anie.202100775

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Radical 1,2,3-tricarbofunctionalization of α-vinyl-β-ketoesters enabled by a carbon shift from an all-carbon quaternary center.

Authors:  Qi Zhang; Mong-Feng Chiou; Changqing Ye; Xiaobin Yuan; Yajun Li; Hongli Bao
Journal:  Chem Sci       Date:  2022-05-02       Impact factor: 9.969

2.  Three-Component Coupling of Arenes, Ethylene, and Alkynes Catalyzed by a Cationic Bis(phosphine) Cobalt Complex: Intercepting Metallacyclopentenes for C-H Functionalization.

Authors:  William G Whitehurst; Junho Kim; Stefan G Koenig; Paul J Chirik
Journal:  J Am Chem Soc       Date:  2022-03-04       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.